Membranous nephropathy: Treatment outline and risk stratification

Membranous nephropathy (MN) is the most common cause of nephrotic syndrome in adult. However, the exact etiology and the best treatment approach are still unclear. It is imperative to understand the nature of and prognosis of MN before initiating treatment which may include disease specific therapy...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autor principal:	Ziad Arabi
Formato:	article
Lenguaje:	EN
Publicado:	Thieme Medical and Scientific Publishers Pvt. Ltd. 2012
Materias:	membranous nephropathy proteinuria cyclophosphamide ponticelli ace inhibitors Medicine R
Acceso en línea:	https://doaj.org/article/c4253f30514b485abf43b61deeedabb8
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:c4253f30514b485abf43b61deeedabb8
record_format	dspace
spelling	oai:doaj.org-article:c4253f30514b485abf43b61deeedabb82021-12-02T17:05:51ZMembranous nephropathy: Treatment outline and risk stratification2231-07702249-446410.4103/2231-0770.102278https://doaj.org/article/c4253f30514b485abf43b61deeedabb82012-07-01T00:00:00Zhttp://www.thieme-connect.de/DOI/DOI?10.4103/2231-0770.102278https://doaj.org/toc/2231-0770https://doaj.org/toc/2249-4464Membranous nephropathy (MN) is the most common cause of nephrotic syndrome in adult. However, the exact etiology and the best treatment approach are still unclear. It is imperative to understand the nature of and prognosis of MN before initiating treatment which may include disease specific therapy based on a careful risk-stratification approach.Ziad ArabiThieme Medical and Scientific Publishers Pvt. Ltd.articlemembranousnephropathyproteinuriacyclophosphamideponticelliace inhibitorsMedicineRENAvicenna Journal of Medicine, Vol 02, Iss 03, Pp 60-64 (2012)
institution	DOAJ
collection	DOAJ
language	EN
topic	membranous nephropathy proteinuria cyclophosphamide ponticelli ace inhibitors Medicine R
spellingShingle	membranous nephropathy proteinuria cyclophosphamide ponticelli ace inhibitors Medicine R Ziad Arabi Membranous nephropathy: Treatment outline and risk stratification
description	Membranous nephropathy (MN) is the most common cause of nephrotic syndrome in adult. However, the exact etiology and the best treatment approach are still unclear. It is imperative to understand the nature of and prognosis of MN before initiating treatment which may include disease specific therapy based on a careful risk-stratification approach.
format	article
author	Ziad Arabi
author_facet	Ziad Arabi
author_sort	Ziad Arabi
title	Membranous nephropathy: Treatment outline and risk stratification
title_short	Membranous nephropathy: Treatment outline and risk stratification
title_full	Membranous nephropathy: Treatment outline and risk stratification
title_fullStr	Membranous nephropathy: Treatment outline and risk stratification
title_full_unstemmed	Membranous nephropathy: Treatment outline and risk stratification
title_sort	membranous nephropathy: treatment outline and risk stratification
publisher	Thieme Medical and Scientific Publishers Pvt. Ltd.
publishDate	2012
url	https://doaj.org/article/c4253f30514b485abf43b61deeedabb8
work_keys_str_mv	AT ziadarabi membranousnephropathytreatmentoutlineandriskstratification
_version_	1718381815230627840

Membranous nephropathy: Treatment outline and risk stratification

Ejemplares similares